Invention Grant
- Patent Title: RSV F-protein and its use
- Patent Title (中): RSV F蛋白及其用途
-
Application No.: US12520321Application Date: 2007-12-18
-
Publication No.: US08372963B2Publication Date: 2013-02-12
- Inventor: Thomas Grunwald , Klaus Ueberla
- Applicant: Thomas Grunwald , Klaus Ueberla
- Applicant Address: CH DE
- Assignee: Pevion Biotech AG,Ruhr-Universitaet Bochum
- Current Assignee: Pevion Biotech AG,Ruhr-Universitaet Bochum
- Current Assignee Address: CH DE
- Agency: Riverside Law LLP
- Priority: DE102006060799 20061221
- International Application: PCT/EP2007/011090 WO 20071218
- International Announcement: WO2008/077527 WO 20080703
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; C07K1/00 ; C07K14/00 ; C07K17/00 ; A61K39/00 ; A61K39/38 ; A61K39/12 ; A61K39/155
Abstract:
The present invention relates to a nucleic acid molecule, which codes for the F-protein of the respiratory syncytial virus (RSV) or a fragment thereof, for the expression in a human cell environment of codon optimized variants of said nucleic acid molecule, vectors and compositions comprising said nucleic acid molecules and the use thereof as vaccines and polypeptides coded by the nucleic acid molecules and method for the production thereof.
Public/Granted literature
- US20100111989A1 RSV F-PROTEIN AND ITS USE Public/Granted day:2010-05-06
Information query
